- Home
- CTSO vs SWIN Comparison
CTSO vs SWIN Comparison
Compare CTSO & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- SWIN
- Stock Information
- Founded
- CTSO 1997
- SWIN 2017
- Country
- CTSO United States
- SWIN Hong Kong
- Employees
- CTSO N/A
- SWIN N/A
- Industry
- CTSO Medical/Dental Instruments
- SWIN
- Sector
- CTSO Health Care
- SWIN
- Exchange
- CTSO Nasdaq
- SWIN Nasdaq
- Market Cap
- CTSO 52.6M
- SWIN 32.1M
- IPO Year
- CTSO N/A
- SWIN 2023
- Fundamental
- Price
- CTSO $1.03
- SWIN $3.61
- Analyst Decision
- CTSO Buy
- SWIN
- Analyst Count
- CTSO 2
- SWIN 0
- Target Price
- CTSO $5.50
- SWIN N/A
- AVG Volume (30 Days)
- CTSO 137.4K
- SWIN 289.4K
- Earning Date
- CTSO 08-12-2025
- SWIN 08-21-2025
- Dividend Yield
- CTSO N/A
- SWIN N/A
- EPS Growth
- CTSO N/A
- SWIN N/A
- EPS
- CTSO N/A
- SWIN N/A
- Revenue
- CTSO $35,332,238.00
- SWIN $3,316,000.00
- Revenue This Year
- CTSO $18.34
- SWIN $29.79
- Revenue Next Year
- CTSO $19.82
- SWIN $54.60
- P/E Ratio
- CTSO N/A
- SWIN N/A
- Revenue Growth
- CTSO 15.37
- SWIN N/A
- 52 Week Low
- CTSO $0.71
- SWIN $1.16
- 52 Week High
- CTSO $1.61
- SWIN $4.40
- Technical
- Relative Strength Index (RSI)
- CTSO 45.35
- SWIN 62.00
- Support Level
- CTSO $0.93
- SWIN $2.93
- Resistance Level
- CTSO $1.16
- SWIN $4.40
- Average True Range (ATR)
- CTSO 0.08
- SWIN 0.50
- MACD
- CTSO -0.02
- SWIN -0.01
- Stochastic Oscillator
- CTSO 27.22
- SWIN 56.62
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.